Uterine cancer incidence and mortality rates are projected to increase significantly over the next three decades in the United States, with incidence-based mortality expected to be nearly three times ...

Incidence and mortality rates for uterine cancer are projected to rise substantially over the next 3 decades, according to ...

The projections come as National Cancer Institute data notes an increase in uterine cancer cases and deaths over the past 30 ...

While incidence and mortality rates for most cancer types have been on the decline in the United States, cases of uterine ...

The relationship between hormone therapy (oestrogen with or without progestogen) and breast cancer risk has been widely ...

Personalized care may hold the key as survival in advanced endometrial cancer remains poor regardless of surgery type or ...

I am a 52-year-old endometrial cancer survivor diagnosed with stage three in 2016. In 2018, I began as a patient partner to a research oncologist who was really concerned about endometrial cancer in ...

The classical endometrial cancer risk factors have been generally thought to act via estrogenic mechanisms, either by increasing estrogen exposure or opposing the effects of estrogen. 16 Obesity is ...

Expert Rev of Obstet Gynecol. 2013;8(3):271-283. The dynamic armamentarium of MIS now includes LESS, a technique that has been used recently in the field of general surgery for procedures such as ...

Endometrial cancer affects the lining of the womb (uterus), known as the endometrium. It is the sixth most common cancer in females worldwide. In 2022, there were 420,242 cases of womb cancer, causing ...

Endometrial cancer is the second most common gynecologic cancer and the sixth most common cancer among women globally. In 2022, ~420,000 cases were diagnosed, which led to ~97,000 deaths worldwide.

Several cancers are becoming more common in young adults, including testicular cancer, melanoma, and cervical cancer. Blood-related cancers like B-cell lymphomas and plasma cell neoplasms are also on ...